• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Pharmaceuticals

Vaccine patch maker Vaxess names former Sanofi exec as chief strategy officer

March 22, 2023 By Sean Whooley

Vaxess Technologies MIMIX vaccine patch

Vaxess Technologies, developer of a shelf-stable vaccine patch, announced today that it named Steve Bende as its new chief strategy officer. Bende previously served as global head of new products at Sanofi Pasteur. He led international, multifunctional teams at the pharmaceutical giant. That included assessing the commercial viability of potential new products. Prior to Sanofi, […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Personnel, Pharmaceuticals Tagged With: Personnel Moves, Vaxess Technologies

Stevanato Group, Thermo Fisher to bring on-body drug delivery system to market

March 21, 2023 By Sean Whooley

Stevanato Group Thermo Fisher collaboration on-body drug delivery system (1)

Stevanato Group (NYSE:STVN) today announced a collaboration with Thermo Fisher Scientific (NYSE:TMO) on drug delivery technology. The partnership aims to bring a fully integrated, on-body delivery system platform for subcutaneous administration to market. Stevanato Group said in a news release that the planned device will be semi-reusable and provide micro-precision basal doses and full-content bolus […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals, Technology Tagged With: Stevanato Group, thermofisherscientific

Vivani Medical wants to bring a subdermal drug delivery implant to the diabetes market

March 1, 2023 By Sean Whooley

Vivani NanoPortal diabetes implant

Where some have tried and failed, Vivani Medical believes its drug-delivering implants can go the distance. When Second Sight Medical and Nano Precision Medical merged last year, the rebranded company — Vivani Medical (Nasdaq:VANI)— had a goal: bring a six-month, subdermal drug delivery implant that treats conditions including type 2 diabetes to market. CEO Dr. […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Implants, Pharmaceuticals, Regulatory/Compliance, Technology Tagged With: Intarcia Therapeutics, Vivani Medical

Eli Lilly is cutting the price of insulin by 70%

March 1, 2023 By Sean Whooley

Eli Lilly

Eli Lilly (NYSE:LLY) announced today that it plans to execute price reductions of 70% for its most commonly prescribed insulins. Indianapolis-based Lilly also plans to expand its Insulin Value Program. This caps patient out-of-pocket costs at $35 or less per month. The company said it took these actions to “help Americans” in a “complex healthcare […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: Eli Lilly, Eli Lilly & Co.

EOFlow invests $7.7B in Pharmeo subsidiary for non-insulin drug delivery development

February 16, 2023 By Sean Whooley

EOFlow EOPatch insulin patch

EOFlow announced today that it plans to invest $7.7 billion (9.9 billion Korean Won) in its wholly-owned Pharmeo subsidiary. The investment aims to advance R&D and commercialization of non-insulin drugs with EOFlow’s wearable drug delivery system. EOFlow intends to finance this investment through paid-in capital increase for the subsidiary. EOFlow owes the actual investment, totaling […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Pharmaceuticals, Technology Tagged With: eoflow, Pharmeo

FDA committee unanimously votes in favor of over-the-counter Narcan from Emergent BioSolutions

February 15, 2023 By Sean Whooley

Emergent Biosolutions Narcan

Emergent BioSolutions (NYSE:EBS) announced today that its over-the-counter Narcan (naloxone HCl) nasal spray received unanimous approval from governing bodies. The vote came from the FDA Nonprescription Drugs Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee. A total of 19 voters decided in favor of the benefit-risk profile for Narcan. The voters support […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Pharmaceuticals, Regulatory/Compliance Tagged With: Emergent BioSolutions, FDA, Narcan

West, Corning expand partnership on drug delivery, packaging solutions

February 8, 2023 By Sean Whooley

West Pharmaceutical Services - updated logo

West Pharmaceutical Services (NYSE:WST) announced today that it expanded its ongoing collaboration with Corning (NYSE:GLW). Exton, Pennsylvania-based West said its partnership now includes exclusive distribution rights for Corning Valor glass vials. It also includes the launch of its first product, West Ready Pack with Corning Valor RTU vials. This technology utilizes SG EZ-fill technology. The […]

Filed Under: Business/Financial News, Drug-Device Combinations, Pharmaceuticals Tagged With: corning, West Pharmaceutical, West Pharmaceutical Services

Owen Mumford wins Pharmapack award for UniSafe auto-injector

February 1, 2023 By Sean Whooley

Owen Mumford Pharmaceutical Services UniSafe auto-injector

Pharmapack Europe today announced that Owen Mumford Pharmaceutical Services received one of its 2023 Pharmapack Awards. The company received recognition in the “Drug Delivery Innovation” category for its UniSafe reusable, connected auto-injector. Woodstock, United Kingdom-based Owen Mumford designed UniSafe as a companion device for its UniSafe 1mL safety syringes. These devices deliver subcutaneous medication. UniSafe […]

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: Owen Mumford

Phillips-Medisize unveils new disposable injector pen

February 1, 2023 By Sean Whooley

Phillips-Medisize disposable injector Pen (1)

Phillips-Medisize, a Molex company, announced today that it expanded its product portfolio with a new disposable pen injector. Hudson, Wisconsin-based Phillips-Medisize designed the new injector for high-volume manufacturing. It intends to offer pharmaceutical companies a familiar, competitive pen injector for faster, more efficient and cost-effective market entry. The company plans to display the pen at […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: Molex, Phillips-Medisize

Aptar Pharma launches metal-free nasal spray pump

January 30, 2023 By Sean Whooley

Aptar Pharma APF Futurity metal-free nasal spray pump

Aptar Pharma announced today that it launched its first metal-free, multidose nasal spray pump, called the APF Futurity. Crystal Lake, Illinois-based Aptar developed APF Futurity to deliver nasal saline and other comparable over-the-counter (OTC) formulations. The company designed the pump specifically for recyclability. It represents Aptar’s first “highly recyclable” nasal spray pump, according to a […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: aptarpharma

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Interim pages omitted …
  • Page 210
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS